Development of liver inflammatory injury in biliary atresia: from basic to clinical research

Sinobol Chusilp1,2, Felicia Balsamo1, Bo Li1

  • 1Division of General and Thoracic Surgery, Translational Medicine Program, University of Toronto, The Hospital for Sick Children, 1526-555 University Ave, Toronto, ON, M5G 1X8, Canada.

Insights

Biliary atresia (BA) causes rapid liver fibrosis in infants through inflammation, even after bile duct repair. Understanding these immune-driven mechanisms is key to preventing cirrhosis progression.

Area of Science:

  • Pediatric Hepatology
  • Immunology
  • Gastroenterology

Background:

  • Biliary atresia (BA) is a severe infant cholangiopathy causing bile duct obliteration.
  • Despite Kasai operation for bile flow, rapid liver fibrosis and cirrhosis progression persist.
  • Fibrosis mechanisms in BA involve inflammation beyond simple bile duct obstruction.

Purpose of the Study:

  • To review evidence on liver inflammatory injury in BA.
  • To explore mechanisms driving rapid liver fibrosis progression in BA.
  • To highlight the role of immune responses in BA fibrogenesis.

Main Methods:

  • Literature review of studies on biliary atresia.
  • Analysis of inflammatory and fibrogenic pathways in BA liver.
  • Synthesis of evidence on immune response activation in BA.

Main Results:

  • BA involves a three-stage fibrogenic cascade: inflammatory injury, myofibroblast activation, and scar formation.
  • Immune response activation post-bile duct injury significantly promotes inflammation and fibrogenesis.
  • Inflammatory cytokines released contribute to the progression of liver fibrosis.

Conclusions:

  • Liver inflammation is a critical factor in rapid fibrosis progression in biliary atresia.
  • Immune-mediated mechanisms significantly contribute to BA-associated liver fibrosis.
  • Targeting inflammatory pathways may offer new therapeutic strategies for BA.